Effects of Nefopam on Streptozotocin-Induced Diabetic Neuropathic Pain in Rats
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background: Nefopam is a centrally acting non-opioid analgesic agent. Its analgesic properties may be related to the inhibitions of monoamine reuptake and the N-methyl-D-aspartate (NMDA) receptor. The antinociceptive effect of nefopam has been shown in animal models of acute and chronic pain and in humans. However, the effect of nefopam on diabetic neuropathic pain is unclear. Therefore, we investigated the preventive effect of nefopam on diabetic neuropathic pain induced by streptozotocin (STZ) in rats. Methods: Pretreatment with nefopam (30 mg/kg) was performed intraperitoneally 30 min prior to an intraperitoneal injection of STZ (60 mg/kg). Mechanical and cold allodynia were tested before, and 1 to 4 weeks after drug administration. Thermal hyperalgesia was also investigated. In addition, the transient receptor potential ankyrin 1 (TRPA1) and TRP melastatin 8 (TRPM8) expression levels in the dorsal root ganglion (DRG) were evaluated. Results: Pretreatment with nefopam significantly inhibited STZ-induced mechanical and cold allodynia, but not thermal hyperalgesia. The STZ injection increased TRPM8, but not TRPA1, expression levels in DRG neurons. Pretreatment with nefopam decreased STZ-induced TRPM8 expression levels in the DRG. Conclusions: These results demonstrate that a nefopam pretreatment has strong antiallodynic effects on STZ-induced diabetic rats, which may be associated with TRPM8 located in the DRG.
Abstract
Background: Nefopam is a centrally acting non-opioid analgesic agent. Its analgesic properties may be related to the inhibitions of monoamine reuptake and the N-methyl-D-aspartate (NMDA) receptor. The antinociceptive effect of nefopam has been shown in animal models of acute and chronic pain and in humans. However, the effect of nefopam on diabetic neuropathic pain is unclear. Therefore, we investigated the preventive effect of nefopam on diabetic neuropathic pain induced by streptozotocin (STZ) in rats. Methods: Pretreatment with nefopam (30 mg/kg) was performed intraperitoneally 30 min prior to an intraperitoneal injection of STZ (60 mg/kg). Mechanical and cold allodynia were tested before, and 1 to 4 weeks after drug administration. Thermal hyperalgesia was also investigated. In addition, the transient receptor potential ankyrin 1 (TRPA1) and TRP melastatin 8 (TRPM8) expression levels in the dorsal root ganglion (DRG) were evaluated. Results: Pretreatment with nefopam significantly inhibited STZ-induced mechanical and cold allodynia, but not thermal hyperalgesia. The STZ injection increased TRPM8, but not TRPA1, expression levels in DRG neurons. Pretreatment with nefopam decreased STZ-induced TRPM8 expression levels in the DRG. Conclusions: These results demonstrate that a nefopam pretreatment has strong antiallodynic effects on STZ-induced diabetic rats, which may be associated with TRPM8 located in the DRG.
참고문헌 (32)
- Durrieu G, "Overview of adverse reactions to nefopam: an analysis of the French Pharmacovigilance database", Fundam Clin Pharmacol, 21, pp.555~558 (2007)
- Girard P, "Role of catecholamines and serotonin receptor subtypes in nefopam-induced antinociception", Pharmacol Res, 54, pp.195~202 (2006)
- Verleye M, "Nefopam blocks voltage-sensitive sodium channels and modulates glutamatergic transmission in rodents", Brain Res, 1013, pp.249~255 (2004)
- Girard P, "Nefopam reduces thermal hypersensitivity in acute and postoperative pain models in the rat", Pharmacol Res, 44, pp.541~545 (2001)
- Biella GE, "Neuronal sensitization and its behavioral correlates in a rat model of neuropathy are prevented by a cyclic analog of orphenadrine", J Neurotrauma, 20, pp.593~601 (2003)
- Elham Saghaei, "Enhancement of Antinociception by Co-administrations of Nefopam, Morphine, and Nimesulide in a Rat Model of Neuropathic Pain", The Korean Journal of Pain, 25(1), pp.7~15 (2012), 대한통증학회
- Schnedl WJ, "STZ transport and cytotoxicity. Specific enhancement in GLUT2-expressing cells", Diabetes, 43, pp.1326~1333 (1994)
- Sima AA, "Experimental diabetic neuropathy: an update", Diabetologia, 42, pp.773~788 (1999)
- Caterina MJ, "The capsaicin receptor : a heat-activated ion channel in the pain pathway", Nature, 389, pp.816~824 (1997)
- Brederson JD, "Targeting TRP channels for pain relief", Eur J Pharmacol, 716, pp.61~76 (2013)
- Wei H, "Attenuation of mechanical hypersensitivity by an antagonist of the TRPA1 ion channel in diabetic animals", Anesthesiology, 111, pp.147~154 (2009)
- Koivisto A, "Inhibiting TRPA1 ion channel reduces loss of cutaneous nerve fiber function in diabetic animals : sustained activation of the TRPA1 channel contributes to the pathogenesis of peripheral diabetic neuropathy", Pharmacol Res, 65, pp.149~158 (2012)
- Wei H, "Roles of cutaneous versus spinal TRPA1channels in mechanical hypersensitivity in the diabetic or mustard oil-treated non-diabetic rat", Neuropharmacology, 58, pp.578~584 (2010)
- Su L, "Role of TRPM8 in dorsal root ganglion in nerve injury-induced chronic pain", BMC Neurosci, 12, pp.120~ (2011)
- Xing H, "TRPM8 mechanism of cold allodynia after chronic nerve injury", J Neurosci, 27, pp.13680~13690 (2007)
- Talbot S, "Key role for spinal dorsal horn microglial kinin B1 receptor in early diabetic pain neuropathy", J Neuroinflammation, 7, pp.36~ (2010)
- Chaplan SR, "Quantitative assessment of tactile allodynia in the rat paw", J Neurosci Methods, 53, pp.55~63 (1994)
- Sung Hoon Kim, "Tumor Necrosis Factor-alpha and Apoptosis Following Spinal Nerve Ligation Injury in Rats", The Korean Journal of Pain, 24(4), pp.185~190 (2011), 대한통증학회
- Li Y, "Mechanical hyperalgesia after an L5 spinal nerve lesion in the rat is not dependent on input from injured nerve fibers", Pain, 85, pp.493~502 (2000)
- 최성수, "Effect of Ethyl Pyruvate on Paclitaxel-Induced Neuropathic Pain in Rats", The Korean Journal of Pain, 26(2), pp.135~141 (2013), 대한통증학회
- Laboureyras E, "Long-term pain vulnerability after surgery in rats: prevention by nefopam, an analgesic with antihyperalgesic properties", Anesth Analg, 109, pp.623~631 (2009)
- Sigaudo-Roussel D, "Diabetic neuropathy in animal models", Drug Discov Today Dis Models, 4, pp.39~44 (2007)
- Leurs R, "Cytochrome P450 metabolic intermediate complex of nefopam", J Pharm Pharmacol, 39, pp.835~837 (1987)
- Barrière DA, "Paclitaxel therapy potentiates cold hyperalgesia in streptozotocin-induced diabetic rats through enhanced mitochondrial reactive oxygen species production and TRPA1 sensitization", Pain, 153, pp.553~561 (2012)
- Wrigley PJ, "Primary afferents with TRPM8 and TRPA1 profiles target distinct subpopulations of rat superficial dorsal horn neurones", Br J Pharmacol, 157, pp.371~380 (2009)
- Knowlton WM, "TRPM8, but not TRPA1, is required for neural and behavioral responses to acute noxious cold temperatures and cold-mimetics in vivo", Pain, 150, pp.340~350 (2010)
- Colburn RW, "Attenuated cold sensitivity in TRPM8 null mice", Neuron, 54, pp.379~386 (2007)
- Klein AH, "Topical application of L-menthol induces heat analgesia, mechanical allodynia, and a biphasic effect on cold sensitivity in rats", Behav Brain Res, 212, pp.179~186 (2010)
- Namer B, "TRPA1and TRPM8 activation in humans : effects of cinnamaldehyde and menthol", Neuroreport, 16, pp.955~959 (2005)
- Calcutt NA, "Potential mechanisms of neuropathic pain in diabetes", Int Rev Neurobiol, 50, pp.205~228 (2002)
- Proudfoot CJ, "Analgesia mediated by the TRPM8 cold receptor in chronic neuropathic pain", Curr Biol, 16, pp.1591~1605 (2006)
- 김석호, "Pain modality and spinal glia expression by streptozotocin induced diabetic peripheral neuropathy in rats", Laboratory Animal Research, 28(2), pp.131~136 (2012), 한국실험동물학회